Key result
Abnormal spirometry before TAVI is not linked to longer hospital stays and reverses within three months.
Why the study?
Abnormal pre-procedural spirometry in severe aortic stenosis undergoing TAVI may reflect hemodynamically mediated pulmonary congestion rather than true chronic pulmonary disease.
Does abnormal baseline spirometry affect short-term clinical outcomes and is it reversible in patients with severe aortic stenosis undergoing TAVI without established pulmonary disease?
Observational (n=69)
No
Does abnormal baseline spirometry affect short-term clinical outcomes and is it reversible in patients with severe aortic stenosis undergoing TAVI without established pulmonary disease?
Abnormal spirometry is common in severe aortic stenosis patients undergoing TAVI but is largely reversible and not associated with adverse short-term outcomes, suggesting a hemodynamic rather than structural pulmonary mechanism.
Answers are grounded in this paper and cite their sources.
Abnormal spirometry should not delay TAVI in severe aortic stenosis without known lung disease; leaves open whether routine testing improves pre-procedural risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Başkurt et al. (2026) conducted an observational in Severe aortic stenosis (n=69). Abnormal spirometry vs. Normal spirometry was evaluated on Length of hospital stay (days) (p=0.111). In patients undergoing TAVI without known pulmonary disease, abnormal baseline spirometry was not associated with a significant increase in length of hospital stay and largely reversed at 3-month follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: